Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

cenexi hsc - dihydroergotamine mesylate (unii: 81axn7r2qt) (dihydroergotamine - unii:436o5hm03c) - dihydroergotamine mesylate injection, usp is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. there have been a few reports of serious adverse events associated with the coadministration of dihydroergotamine and potent cyp3a4 inhibitors, such as protease inhibitors and macrolide antibiotics, resulting in vasospasm that led to cerebral ischemia and/or ischemia of the extremities. the use of potent cyp3a4 inhibitors (i.e., ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, troleandomycin, ketoconazole, itraconazole) with dihydroergotamine is, therefore, contraindicated ( see warnings, cyp3a4 inhibitors ). dihydroergotamine mesylate injection, usp should not be given to patients with ischemic heart disease (e.g., angina pectoris, history of myocardial infarction, or documented silent ischemia) or to patients who have clinical symptoms or findings consistent with coronary artery vasospasm inc

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

bausch health us, llc - dihydroergotamine mesylate (unii: 81axn7r2qt) (dihydroergotamine - unii:436o5hm03c) - dihydroergotamine mesylate 4 mg in 1 ml - migranal (dihydroergotamine mesylate) nasal spray is indicated for the acute treatment of migraine headaches with or without aura. migranal (dihydroergotamine mesylate) nasal spray is not intended for the prophylactic therapy of migraine or for the management of hemiplegic or basilar migraine. there have been a few reports of serious adverse events associated with the coadministration of dihydroergotamine and potent cyp 3a4 inhibitors, such as protease inhibitors and macrolide antibiotics, resulting in vasospasm that led to cerebral ischemia and/or ischemia of the extremities. the use of potent cyp 3a4 inhibitors (ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, troleandomycin, ketoconazole, itraconazole) with dihydroergotamine is, therefore contraindicated (see warnings, cyp 3a4 inhibitors ). migranal (dihydroergotamine mesylate) nasal spray should not be given to patients with ischemic heart disease (angina pectoris, history of myocardial infarction, or documented silent ischemia) or to p

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

rosedale therapeutics - ergotamine tartrate (unii: mru5xh3b48) (ergotamine - unii:pr834q503t) - ergotamine tartrate 2 mg - ergomar® is indicated as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants or a so-called "histaminic cephalalgia". coadministration of ergotamine with potent cyp 3a4 inhibitors (ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin and troleandomycin) has been associated with acute ergot toxicity (ergotism) characterized by vasospasm and ischemia of the extremities (see precautions: drug interactions ), with some cases resulting in amputation. there have been rare reports of cerebral ischemia in patients on protease inhibitor therapy when ergotamine was coadministered, at least one resulting in death. because of the increased risk for ergotism and other serious vasospastic adverse events, ergotamine use is contraindicated with these drugs and other potent inhibitors of cyp 3a4 (e.g., ketoconazole, itraconazole) (see warnings: cyp 3a4 inhibitors ). ergomar® sublingual tablets may cause fetal harm when administered to pregnant women. ergomar® sublingual tablets are con

Malaysia - Tiếng Anh - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

a. menarini singapore pte. ltd. - ergotamine tartrate; caffeine -

Bỉ - Tiếng Anh - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amdipharm ltd. - caffeine 100 mg; ergotamine tartrate 2 mg - suppository - 2 mg - 100 mg - ergotamine tartrate 2 mg; caffeine 100 mg - ergotamine, combinations excl. psycholeptics; n02ca72 ergotamine, combinations with psycholeptics

Canada - Tiếng Anh - Health Canada

novartis pharmaceuticals canada inc - ergotamine (ergotamine tartrate); caffeine; belladonna; pentobarbital - suppository - 2mg; 100mg; 0.25mg; 60mg - ergotamine (ergotamine tartrate) 2mg; caffeine 100mg; belladonna 0.25mg; pentobarbital 60mg - sympatholytic (adrenergic blocking) agents

Canada - Tiếng Anh - Health Canada

sandoz canada incorporated - dihydroergotamine mesylate - liquid - 1mg - dihydroergotamine mesylate 1mg - sympatholytic (adrenergic blocking) agents

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

gland pharma limited - dihydroergotamine mesylate (unii: 81axn7r2qt) (dihydroergotamine - unii:436o5hm03c) - dihydroergotamine mesylate injection is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. there have been a few reports of serious adverse events associated with the coadministration of dihydroergotamine and potent cyp3a4 inhibitors, such as protease inhibitors and macrolide antibiotics, resulting in vasospasm that led to cerebral ischemia and/or ischemia of the extremities. the use of potent cyp3a4 inhibitors (i.e., ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, troleandomycin, ketoconazole, itraconazole) with dihydroergotamine is, therefore contraindicated (see warnings: cyp3a4 inhibitors).   dihydroergotamine mesylate injection should not be given to patients with ischemic heart disease (e.g., angina pectoris, history of myocardial infarction, or documented silent ischemia) or to patients who have clinical symptoms or findings consistent with coronary artery vasospasm including prinzmetal’s variant angi

Canada - Tiếng Anh - Health Canada

novartis pharmaceuticals canada inc - pentobarbital sodium; ergotamine (ergotamine tartrate); caffeine; belladonna - tablet - 30mg; 1mg; 100mg; 0.125mg - pentobarbital sodium 30mg; ergotamine (ergotamine tartrate) 1mg; caffeine 100mg; belladonna 0.125mg - sympatholytic (adrenergic blocking) agents

Canada - Tiếng Anh - Health Canada

pharmascience inc - dihydroergotamine mesylate - liquid - 4mg - dihydroergotamine mesylate 4mg - sympatholytic (adrenergic blocking) agents